Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Pathways

On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

Carol J. Thiele, Zhijie Li and Amy E. McKee
Carol J. Thiele
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhijie Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy E. McKee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-08-0651 Published October 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematic representation of Trk receptor tyrosine kinases and major signal transduction pathways. The trk receptors have an extracellular ligand-binding domain, a singular transmembrane region, and an intracellular region of variable length. The round green filled circles represent the cysteine-rich regions, which are separated by fibronectin type III repeats (jagged line). The open green circles represent the Ig-like domains that bind the dimeric BDNF monomers leading to dimerization of the TrkB receptors and activation of the intracellular TrkB-tyrosine kinase (TK) domain (rectangle filled with circles). Activation of the TrkB-TK leads to phosphorylation (P) of a number of tyrosines (Y) in the TK domain, as well as the juxtamembrane domain. These PY residues serve as docking sites for cytoplasmic proteins, such as Shc and PLCγ, whose recruitment in turn leads to activation of downstream mediators of the MAPK, PLCγ and PI-3 kinase pathways. Ultimately, these signals are transduced to the nucleus to mediate transcriptional programs that regulate cellular functions, such as synaptic plasticity, differentiation, growth, survival, and motility. Other members of the Trk family, TrkA and TrkC, are depicted to illustrate the structural conservation of this gene family. P75 is a pan-neurotrophin (NT) receptor, which is structurally in the Death Receptor family of membrane-bound receptors.

PreviousNext
Back to top
Clinical Cancer Research: 15 (19)
October 2009
Volume 15, Issue 19
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Carol J. Thiele, Zhijie Li and Amy E. McKee
Clin Cancer Res October 1 2009 (15) (19) 5962-5967; DOI: 10.1158/1078-0432.CCR-08-0651

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Carol J. Thiele, Zhijie Li and Amy E. McKee
Clin Cancer Res October 1 2009 (15) (19) 5962-5967; DOI: 10.1158/1078-0432.CCR-08-0651
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Trks in Cancer
    • Clinical-Translational Advances
    • Disclosure of Potential Conflicts of Interest
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Targeting of the Liver Microenvironment
  • Targeting the Protein Kinase Wee1 in Cancer
  • Metabolic Control of Histone Methylation and Gene Expression
Show more Molecular Pathways
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement